Hypersensitivity Clinical Correlations Flashcards

1
Q

Hypersensitivity reactions

A

Excessive, undesirable reaction produced by the normal immune system

  • exaggerated and harmful response
  • mild to life threatening
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sensitizaiton

A

Initial exposure to an antigen

- subsequent exposure to the same antigen results in hypersensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Type 1

A

Immediate!

  • minor symptoms to death
  • present 15-30 min after antigen exposure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Type 1 - phase 1

A

Sensitization

  • antigens encountered at mucosal and cutaneous surfaces
  • IgE production to inital encounter
  • asymptomatic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Type 1 - phase 1 example

A
DC within the bronchial epithelium encounters an inhaled antigen
--> DC travels to lymph node to signal Th2 --> IL-4, 13 induces a humoral response --> B cells are directed to a class switch to IgE production --> IgE binds to tissue mast cells, where they reside at mucosal/cutaneous surfaces at the original site of encounter = sensitization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Type 1 - phase 1 summary

A
  • mediated by IgE

- primary cellular component is the mast cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Type 1 - phase 2

A

Re-exposure

  • exposure to the same allergen = cross linking (occurs when antigen is bound by 2 or more IgE)
  • initiates signal pathway in mast cells and triggers degranulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mast cell degranulation

A

Release of cytokines (IL-4,5,6 and inflammatory mediators)

- results in pruritus, bronchoconstriction, and vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Type 1 active substances

A
  • histamine!
  • heparin
  • leukotrienes
  • prostaglandin D2
  • platelet activating factor
  • eosinophil chemotactic factor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical consequence of mast cell degranulation

A

Immediate hypersensitivity (occurs within 15-20 min)

  • vasodilation/vascular permeability = tissue edema
  • bronchoconstriction (smooth muscle contraction)
  • interaction with local nerves = pruritis
  • platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Type 1 - late phase

A

Occurs 4-24 hrs after antigen exposure

- recruitment of eosinophils and macrophages into the tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Presence of ______ is the hallmark of type 1 hypersensitivity

A

Eosinophils!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Majority of type 1 reactions are ______

A

Localized

  • skin: dermatitis
  • respiratory: asthma, allergic rhinitis
  • intestinal tract: food allergy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Type 1 - systemic reactions

A

Often involve drugs or insect stings

- causes anaphylactic reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Anaphylactic reaction signs

A
  • bronchoconstriction and dyspnea
  • hypotension
  • tachycardia
  • vomiting/diarrhea
  • dizziness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Anaphylactic reaction treatment

A
  • epinephrine
  • fluids
  • oxygen
  • antihistamines
  • steroids
  • supportive care
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Feline Asthma

A

Lower airway disease, limiting airflow due to reduced airway diameter

  • airway inflammation
  • accumulating airway mucus
  • airway smooth muscle contraction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What 2 cells play an important role in feline asthma?

A

Interactions between T cells and eosinophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Feline asthma treatment

A

Need to address inflammation and bronchoconstriction

- steroids and bronchodilators

20
Q

Adverse vaccine reactions

A

Due to IgE mediated degranulation of mast cells located in the skin = histamine and leukotriene release to deeper skin layers
- causes angioedema, urticaria, and pruritis

21
Q

Type 2 hypersensitivity

A

Aka cytotoxic or antibody mediated hypersensitivity

  • affects variety of organs
  • involves destruction of a target cell and the sensitization is to an antigen displayed on the surface of that target cell
22
Q

Type 2 - antibody production

A

Produced to endogenous antigens or exogenous substances (haptens) which attach to cell membranes and cause subsequent tissue damage
- mediated by IgG or IgM (with or without complement involvement)

23
Q

Type 2 - pathophysiology

A

Rapid destruction occurs via activation of classical complement pathway and formation of MAC
- takes longer when target cell destruction involves NK cell destruction or macrophage phagocytosis of the antibody dependent cell mediated pathway

24
Q

Type 2 - examples

A
  • IMHA
  • transfusion reactions
  • myasthenia gravis
  • pemphigus
25
IMHA
Antibodies coat RBC and induce destruction - leads to severe damage by antibodies and complement = intravascular hemolysis - macrophages recognize Fc portion of antibody and remove the targeted RBC
26
Intravascular hemolysis leads to _____ and ______
Hemoglobinemia and hemoglobinuria | - build up of hemoglobin due to RBC destruction
27
Extravascular hemolysis
Destruction of RBCs by spleen/liver macrophages
28
What is the hallmark of IMHA?
Autoagglutination
29
How do you treat IMHA?
Immunosuppressive medications
30
Blood transfusion in cats
Type A - no or low levels of pre-formed anti-B alloantibodies Type B - high levels of pre-formed anti-A alloantibodies
31
Type A cat receiving type B blood
Minor risk, but possible for transfusion reactions
32
Type B cat receiving type A blood
Much greater risk for transfusion reaction
33
Myasthenia gravis
Generalized muscle weakness that worsens with exercise, and megaesophagus - antibodies against Ach receptors - treat with cholinesterase inhibitors
34
Pemphigus foliaceus
Most common autoimmune disease of dogs - causes lethargy, febrile, lymphadenopathy - widespread distribution over head, face, ears - treat with immunosuppressive steroids
35
Type 3 hypersensitivity
Immune complex hypersensitivity | - formation of soluble immune complexes in the blood and subsequent tissue deposition and tissue damage
36
Type 3 - pathophysiology
Excessive production of antigen specific IgG antibody with sensitization - re - exposure causes antibody binding to antigen in circulation and formation of antigen/antibody complexes
37
Immune complexes are comprised of
Antibodies, antigens, platelets, and neutrophils
38
Type 3 - signs
Occur once immune complexes are deposited into tissues - inflammatory response - complement activation - recruitment of inflammatory cells to site of inflammation (neutrophils and macrophages)
39
Where do the immune complexes deposit?
Within the walls of the capillaries of differing tissues - kidneys - skin - joints
40
Vasculitis
Complement fixation and triggering of inflammatory pathways within the vascular walls - leads to: joint pain, cutaneous lesions, and protein losing nephropathy
41
Type 3 - cause
Antigenic cause is often not determined | - idiopathic or immune-mediated
42
Immune-mediated polyarthritis
Inflammatory disease where microbial organisms cannot be cultured from the joints and where the immune system plays an important role in the pathogenesis
43
Type 4 hypersensitivity
Cell mediated, or "delayed" type - prolonged onset of action (24-72 hrs) - sensitization leads to generation of antigen specific T lymphocytes (Th1)
44
Type 4 - pathophysiology
Subsequent exposure leads to activation of sensitized Th1 cells and movement to site of exposure - release of cytokines and recruitment of inflammatory cells (macrophages, Th cells, Tc cells)
45
What causes direct damage in type 4?
Cytotoxic T cells | - recruited by helper T cells
46
What is the most significant type 4 manifestation?
Contact allergy | - inappropriate inflammatory response at cutaneous site of challenge